companies / translucencebio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 1,400,0001.4M | ○ |
|---|---|---|
| founded | 2018 | |
| hq | irvine, ca, usa | |
| industry | unknown | |
| stage | null |
Translucence Biosystems develops 3D whole-brain imaging and analysis tools that combine tissue clearing, light-sheet microscopy, and AI quantification. It serves CNS-drug developers and academic neuroscience labs scoring drug effects at single-cell resolution across whole organs. Its end-to-end pipeline from sample prep to cellular quantification is the kind of stack a typical CRO has to outsource piecewise.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-01 | grant | 1,400,0001.4M | null | ○ |
Cloudflare, reCAPTCHA, Google Analytics, Google Font API, Google Hosted Libraries, Google Tag Manager, Stripe, jQuery CDN, jquery 3.5.1, moment 0, @stripe/stripe-js
| fact | status | src |
|---|---|---|
| Grant, $1.4M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |